Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 1 · 33.3%High 0 · 0%

Endovenous laser ablation (EVLA) vs radiofrequency ablation

Long‐term recurrence (> 5 years) · people with GSV incompetence

Endovenous laser ablation (EVLA) may leads to higher long‐term recurrence (> 5 years) compared with radiofrequency ablation (RFA) (low certainty).

1 finding from 1 review

Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
OR 2.77 [1.52, 5.06]
1 study · 291 participants
Low

Endovenous laser ablation (EVLA) vs foam sclerotherapy

Long‐term recurrence (> 5 years) · people with GSV incompetence

It is very uncertain whether endovenous laser ablation (EVLA) changes long‐term recurrence (> 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (very low certainty).

1 finding from 1 review

Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
OR 1.08 [0.4, 2.87]
2 studies · 418 participants
Very low

Endovenous laser ablation (EVLA) vs SFJ ligation and stripping (HL/S)

Long‐term recurrence (> 5 years) · people with GSV incompetence

Endovenous laser ablation (EVLA) showed no clear difference in long‐term recurrence (> 5 years) compared with SFJ ligation and stripping (HL/S) (moderate certainty).

1 finding from 1 review

Interventions for great saphenous vein incompetence 2021 · Cochrane Headline outcomes only
OR 1.09 [0.68, 1.76]
7 studies · 1267 participants
Moderate